Share
Åsa Runnäs
Resitu, a pioneering Swedish MedTech company revolutionizing breast tumor excision, has appointed Åsa Runnäs as its new Chief Executive Officer (CEO).
This appointment signals a strategic shift as the company advances from product development to full-scale commercialization of its innovative excision device.
A founding member and core investor in Resitu, Runnäs previously held the role of Chief Strategy Officer, contributing significantly to the company’s direction and growth. With more than 20 years of experience in medical device regulation, commercialization, and executive leadership - including as CEO of several MedTech consultancy firms - Runnäs brings a wealth of industry insight and operational acumen to her new role.
Her appointment comes at a critical juncture as Resitu prepares to launch its first-in-class, vacuum-assisted handheld device for the minimally invasive excision of breast tumors. Designed to provide a more precise, patient-friendly alternative to traditional surgical biopsies, the device promises to improve diagnostic accuracy, reduce procedure time, and enhance overall patient experience.
Excitement around the technology is gaining momentum. Resitu recently showcased the device in hands-on workshops with 40 leading breast surgeons at the Uppsala Breast Meeting hosted by Uppsala University. The live demonstrations highlighted the device’s simplicity, clinical value, and potential for integration into real-world breast cancer diagnostics.
Developed in collaboration with top breast surgeons, the device is tailored to address a significant unmet need in global breast cancer care - offering an effective and accessible tool for complete tumor excision in outpatient settings.
Under Runnäs’s leadership, Resitu is committed to delivering this transformative technology to healthcare systems worldwide, enabling clinicians to perform precise, minimally invasive breast tumor removals with greater ease and efficiency.
Related posts
-(2).jpg "Vicarious Surgical Appoints Joseph Doherty as Chairman of the Board")
